DNAPrint genomics Forensics Technology Plays Key Role in Probe of California's Mammoth Lakes Murder Case

DNAPrint genomics Forensics Technology Plays Key Role in Probe of
California's Mammoth Lakes Murder Case 


SARASOTA, Fla., May 11  /PRNewswire-FirstCall/ -- DNAPrint genomics (OTC:DNAP)
(BULLETIN BOARD: DNAP)  today announced that its DNAWITNESS(TM) technology for
law enforcement forensics continues to draw media attention for changing the
direction of the investigation into the highly publicized Mammoth Lakes murder
case in California's Southern Sierras.

According to a story aired on Tuesday, May 10, by KGO-TV, an ABC affiliate in
San Francisco, the Mammoth Lakes murder has "become a test case for
experimental science and could become the model for the future of crime-
fighting." Through its proprietary technology, DNAPrint genomics completely
shifted the focus of the investigation into the unsolved murder.

In May 2003 after the winter snowmelt, the remains of a body dug up by wild
animals were found in a shallow grave at the resort town's Shady Rest
Campground. The remains were sent to the San Francisco Medical Examiner's
office, which determined that the victim was a woman, 30 to 40 years old, of
Southeast Asian descent. In addition, this report was corroborated by
eyewitness reports of an Asian woman complaining about an abusive spouse or
significant other. However, investigators shifted the focus of their
investigation after a DNA sample sent to DNAPrint for analysis in August 2004
determined that the victim was 100% Native American.

Utilizing new techniques from DNAPrint and other scientific laboratories,
authorities built a facial reconstruction that turned out to be a near look-
alike of an artist's sketch drawn from a description of a woman seen at the
park's Forest Service Visitor's Center in the fall of 2002. The woman had
complained to a Visitor's Center employee that a man accompanying her was being
mean and harassing her. A year later, after seeing the face reconstruction, the
employee concluded that it was that of the woman who was at the visitor's
center. Authorities are trying to determine the identity of the man who was
with her.

"DNAPrint's DNAWITNESS(TM) forensics technology already has played a key role
in the apprehension of a serial killer in Louisiana and, in addition to the
Mammoth Lakes murder, currently is being utilized in more than 80 criminal
investigations," stated Richard Gabriel, the Company's President and Chief
Executive Officer. "Our technology has had nationwide impact on a number of
high-profile murder investigations. We also had a case in Concord, Calif., in
which the targeted groups in a murder, based on eyewitness reports, were
Hispanic and Asian gang members.  However, it turned out that, based on
DNAPrint's DNA analysis, the individual who committed that murder was
Caucasian."

About DNAPrint genomics, Inc.

DNAPrint genomics, Inc. uses proprietary human genome research methods to
develop genomic-based services and products. The Company's ANCESTRYbyDNA(TM) is
a consumer product for individuals interested in learning their family
heritage.  DNAWITNESS(TM) is a forensics market tool for analyzing DNA evidence
recovered at a crime scene. DNAPrint is also developing products in the
pharmacogenomic market, including OVANOME(TM), a genomic-based diagnostic tool
that matches ovarian cancer patients with the most suitable form and dose of
chemotherapy, and STATINOME(TM), a test for the cardiac drug market to
determine whether patients will be good or poor responders to statins, which
are effective in cholesterol reduction. For more information about the company,
please visit http://www.dnaprint.com/ .

Forward-Looking Statements

All statements in this press release that are not historical are forward-
looking statements. Such statements are subject to risks and uncertainties that
could cause actual results to differ materially from those projected,
including, but not limited to, uncertainties relating to technologies, product
development, manufacturing, market acceptance, cost and pricing of DNAPrint's
products, dependence on collaborations and partners, regulatory approvals,
competition, intellectual property of others, and patent protection and
litigation. DNAPrint genomics, Inc. expressly disclaims any obligation or
undertaking to release publicly any updates or revisions to any forward-
looking statements contained herein to reflect any change in DNAPrint's
expectations with regard thereto or any change in events, conditions or
circumstances on which any such statements are based.

   Company Contact:
   Richard Gabriel
   President and CEO
   941-366-3400
        -or-
   Ron Stabiner
   The Wall Street Group, Inc.
   212-888-4848


DATASOURCE: DNAPrint genomics, Inc.



CONTACT:  Richard Gabriel, President and CEO of DNAPrint genomics,

[phone]; or Ron Stabiner of The Wall Street Group, Inc.,

[phone], for DNAPrint genomics



Web site:  http://www.dnaprint.com/ 

Copyright